Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Yuko Ishizaka"'
Autor:
Dan Kawamori, Yoko Kageyama, Takayuki Tanaka, Yuko Ishizaka, Shigero Hosoe, Naoto Katakami, Iichiro Shimomura
Publikováno v:
Journal of Diabetes Investigation, Vol 14, Iss 1, Pp 111-121 (2023)
ABSTRACT Aims/Introduction In addition to absolute insulin deficiency, dysregulated glucagon in type 1 diabetes is considered pathophysiologically important. Previously, we confirmed the presence of dysregulated glucagon in Japanese patients with typ
Externí odkaz:
https://doaj.org/article/822c12480fda441896d9717d9c9aafaf
Publikováno v:
Clinical Medicine Insights: Cardiology, Vol 2014, Iss Suppl. 3, Pp 1-5 (2014)
Externí odkaz:
https://doaj.org/article/030e2e590c874dc79662ee6bd6683c78
Autor:
Mihoko Shiio, Nobuya Maeda, Atsushi Iwata, Kenji Ishibashi, Kenji Ishii, Hiroshi Takuma, Yuko Ishizaka, Yasuhisa Sakurai
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 18, p2555-2565, 11p
Autor:
Dan Kawamori, Yoko Kageyama, Takayuki Tanaka, Yuko Ishizaka, Shigero Hosoe, Naoto Katakami, Iichiro Shimomura
Publikováno v:
Journal of diabetes investigationREFERENCES. 14(1)
In addition to absolute insulin deficiency, dysregulated glucagon in type 1 diabetes is considered pathophysiologically important. Previously, we confirmed the presence of dysregulated glucagon in Japanese patients with type 1 diabetes, and found a s
Autor:
Ivonne M.C.M. Rietjens, Takayuki Tanaka, Yuko Ishizaka, Yoko Masuzawa, Keng Ngee Teoh, Hidehiro Nakamura
Publikováno v:
Food and Chemical Toxicology 147 (2021)
Food and Chemical Toxicology, 147
Food and Chemical Toxicology, 147
Use of a default methodology for establishment of a health-based guidance value (HBGV) resulted in a group acceptable daily intake (ADI) for glutamates (E620-625) below the normal dietary glutamate intake, and also lower than the intake of free gluta
Publikováno v:
Annals of clinical and laboratory science. 49(4)
We reported that the body mass index (BMI) may exert a negative effect on glycated albumin (GA) in non-diabetic subjects and patients with type 2 diabetes mellitus. In addition, we suggested a mechanism in which chronic inflammation in obesity may en
Autor:
Yuko Ishizaka, Minoru Yamakado, Sumie Okahata, Masao Yano, Teruo Shiba, Takako Mitsumatsu, Kentaro Sakamoto
Publikováno v:
Diabetes. 67
Background: Increased oxidative stress plays a role in the progression of atherosclerosis. Yet only few reports in NOD. Method: Derivatives of reactive oxygen metabolites(d-ROMs) and biological antioxidant potential (BAP) were measured in 859 subject
Autor:
Hiroshi Yamamoto, Takayuki Tanaka, Takashi Daimon, Hiroshi Miyano, Kenji Nagao, Akiko Toda, Yuko Ishizaka, Minoru Yamakado, Katsuhisa Horimoto, Michiharu Komatsu, Akira Imaizumi, Mizuki Tani
Publikováno v:
Scientific Reports
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Scientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
Fatty liver disease (FLD) increases the risk of diabetes, cardiovascular disease, and steatohepatitis, which leads to fibrosis, cirrhosis, and hepatocellular carcinoma. Thus, the early detection of FLD is necessary. We aimed to find a quantitative an
Publikováno v:
Clinica Chimica Acta. 438:19-23
Background Glycated albumin (GA) is known to be negatively regulated by body mass index (BMI) in non-diabetic subjects and patients with type 2 diabetes mellitus (T2DM). In non-diabetic subjects, a mechanism has been proposed in which chronic inflamm
Publikováno v:
Hypertension Research. 38:163-168
Excess salt intake is a risk factor for increased blood pressure (BP) and hypertension. To prevent hypertension, the reduction of salt intake is promoted in many countries. For people with hypertension or cardiovascular disease (CVD), a more severe r